Amplification of Recombinant Adenoviral Transgene Products Occurs by Inhibition of Histone Deacetylase

This publication has 47 references indexed in Scilit:

• TransComplementation of an E1A-Deleted Adenovirus with Codelivered E1A Sequences to Make Recombinant Adenoviral Producer Cells
  Human Gene Therapy, 1994
• Elevation of large‐T antigen production by sodium butyrate treatment of SV40‐transformed WI‐38 fibroblasts
  Journal of Cellular Biochemistry, 1992
• Pharmacokinetic Studies of N-Butyric Acid Mono- and Polyesters Derived from Monosaccharides
  Journal of Pharmaceutical Sciences, 1992
• New stable butyrate derivatives alter proliferation and differentiation in human mammary cells
  International Journal of Cancer, 1991
• Antibody-mediated targeting of differentiation inducers to tumor cells: Inhibition of colonic cancer cell growth in vitro and in vivo a preliminary note
  Biochemical and Biophysical Research Communications, 1989
• Clinical pharmacology of sodium butyrate in patients with acute leukemia
  European Journal of Cancer and Clinical Oncology, 1987
• Diet, butyric acid and differentiation of gastrointestinal tract tumours
  Medical Hypotheses, 1985
• Effects of n-Butyrate on Epstein--Barr Virus-carrying Lymphoma Lines
  Journal of General Virology, 1982
• Reversible effects of Na-butyrate on histone acetylation
  Biochemical and Biophysical Research Communications, 1978
• Two adenovirus mRNAs have a common 5′ terminal leader sequence encoded at least 10 kb upstream from their main coding regions
  Cell, 1977